BIOMARIN PHARMACEUTICAL INC - FORM 10-K - EX-32.1 - CERTIFICATION OF CEO AND CFO PURSUANT TO SECTION 906 - February 26, 2010

Attached files

file filename
10-K - FORM 10-K - BIOMARIN PHARMACEUTICAL INCd10k.htm
EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex311.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 - BIOMARIN PHARMACEUTICAL INCdex312.htm
EX-23.1 - CONSENT OF KPMG LLP - BIOMARIN PHARMACEUTICAL INCdex231.htm
EX-23.2 - CONSENT OF PRICEWATERHOUSECOOPERS, LLP - BIOMARIN PHARMACEUTICAL INCdex232.htm
EX-10.37 - STOCK PURCHASE AGREEMENT - BIOMARIN PHARMACEUTICAL INCdex1037.htm
EX-21.1 - SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL INC. - BIOMARIN PHARMACEUTICAL INCdex211.htm
EX-99.1 - BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS - BIOMARIN PHARMACEUTICAL INCdex991.htm

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Annual Report on Form 10-K of BioMarin Pharmaceutical Inc. (the “Company”) for the year ended December 31, 2009, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), we, Jean-Jacques Bienaimé, and Jeffrey H. Cooper, hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ JEAN-JACQUES BIENAIMÉ

Jean-Jacques Bienaimé

Chief Executive Officer

February 25, 2010

/s/ JEFFREY H. COOPER

Jeffrey H. Cooper

Chief Financial Officer

February 25, 2010

Stock widget

Investing forum

BIOMARIN PHARMACEUTICAL INC Reports